In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other medical technology stocks. The MedTech sector is crucial in healthcare, which ...
Peptides were separated using the following gradient: 0–18 min, 6%–22% B; 18–26 min, 22%–30% B; 26–27 min, 30%–80% B; and 27–30 min, 80% B, at a constant flow rate of 450 nL/min on a nanoElute UHPLC ...
As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...
Similar improvements are observed in immunopeptidomics. Bruker expects to launch the new AIP on the timsTOF Ultra 2 system at ASMS 2025 with timsTOF Ultra 2 field upgradability. B. DeutEx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback